Effect of laminin 332 on motility and invasion in bladder cancer

Sung-Gu Kang, Young Ran Ha, Young Hwii Ko, Seok Ho Kang, Kwan Joong Joo, Hyun Yee Cho, Hong Seok Park, Chul Hwan Kim, Soon Young Kwon, Je-Jong Kim, Jun Cheon, Jeong Gu Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We examined the correlation between laminin 332 and malignancy in bladder cancer patients, and, using a strain of invasive bladder cancer cells, determined whether laminin 332 causes bladder cancer motility and invasion. To investigate the correlation between laminin 332 g2 distribution and patient outcome, we performed a semiquantitative immunohistochemical analysis of 35 paraffin-embedded samples using the antibody D4B5, which is specific for the laminin 5 γ2 chain. To evaluate the role of laminin 332 in NBT-II cell motility and invasion, we used a scratch assay and the Boyden chamber chemoinvasion system. Tumor stage and grade were significantly correlated with a loss of laminin 332 γ2 chain from the basement membrane (p = 0.001) and its retention in the cytoplasm (p = 0.001) (Kruskal-Wallis test). Kaplan-Meier survival curves revealed an association between the risk of progression and cytoplasmic retention of the laminin 332 γ2 chain. In addition, an in vitro scratch assay showed an increase in the migration of cells treated with laminin 332 from their cluster. The Boyden chamber assay showed that laminin 332 potentiated NBT-II cell invasion. Immunohistochemistry results showed that bladder cancer patients with a higher malignancy expressed more laminin 332. The in vitro scratch and invasion assay showed that laminin 332 stimulated the motility and invasion of bladder cancer cells. The invasion assay explains the correlation between laminin 332 expression and bladder cancer malignancy.

Original languageEnglish
Pages (from-to)422-429
Number of pages8
JournalKaohsiung Journal of Medical Sciences
Volume29
Issue number8
DOIs
Publication statusPublished - 2013 Aug 1

Fingerprint

Urinary Bladder Neoplasms
Cell Movement
kalinin
Neoplasms
Kaplan-Meier Estimate
Basement Membrane
Paraffin
Cytoplasm
Immunohistochemistry

Keywords

  • Invasion
  • Laminin 332
  • Prognosis
  • Urothelial cell carcinoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of laminin 332 on motility and invasion in bladder cancer. / Kang, Sung-Gu; Ha, Young Ran; Ko, Young Hwii; Kang, Seok Ho; Joo, Kwan Joong; Cho, Hyun Yee; Park, Hong Seok; Kim, Chul Hwan; Kwon, Soon Young; Kim, Je-Jong; Cheon, Jun; Lee, Jeong Gu.

In: Kaohsiung Journal of Medical Sciences, Vol. 29, No. 8, 01.08.2013, p. 422-429.

Research output: Contribution to journalArticle

@article{d2b14c18571a4e90a9a6a8191c1bd423,
title = "Effect of laminin 332 on motility and invasion in bladder cancer",
abstract = "We examined the correlation between laminin 332 and malignancy in bladder cancer patients, and, using a strain of invasive bladder cancer cells, determined whether laminin 332 causes bladder cancer motility and invasion. To investigate the correlation between laminin 332 g2 distribution and patient outcome, we performed a semiquantitative immunohistochemical analysis of 35 paraffin-embedded samples using the antibody D4B5, which is specific for the laminin 5 γ2 chain. To evaluate the role of laminin 332 in NBT-II cell motility and invasion, we used a scratch assay and the Boyden chamber chemoinvasion system. Tumor stage and grade were significantly correlated with a loss of laminin 332 γ2 chain from the basement membrane (p = 0.001) and its retention in the cytoplasm (p = 0.001) (Kruskal-Wallis test). Kaplan-Meier survival curves revealed an association between the risk of progression and cytoplasmic retention of the laminin 332 γ2 chain. In addition, an in vitro scratch assay showed an increase in the migration of cells treated with laminin 332 from their cluster. The Boyden chamber assay showed that laminin 332 potentiated NBT-II cell invasion. Immunohistochemistry results showed that bladder cancer patients with a higher malignancy expressed more laminin 332. The in vitro scratch and invasion assay showed that laminin 332 stimulated the motility and invasion of bladder cancer cells. The invasion assay explains the correlation between laminin 332 expression and bladder cancer malignancy.",
keywords = "Invasion, Laminin 332, Prognosis, Urothelial cell carcinoma",
author = "Sung-Gu Kang and Ha, {Young Ran} and Ko, {Young Hwii} and Kang, {Seok Ho} and Joo, {Kwan Joong} and Cho, {Hyun Yee} and Park, {Hong Seok} and Kim, {Chul Hwan} and Kwon, {Soon Young} and Je-Jong Kim and Jun Cheon and Lee, {Jeong Gu}",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.kjms.2012.12.003",
language = "English",
volume = "29",
pages = "422--429",
journal = "Kaohsiung Journal of Medical Sciences",
issn = "1607-551X",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "8",

}

TY - JOUR

T1 - Effect of laminin 332 on motility and invasion in bladder cancer

AU - Kang, Sung-Gu

AU - Ha, Young Ran

AU - Ko, Young Hwii

AU - Kang, Seok Ho

AU - Joo, Kwan Joong

AU - Cho, Hyun Yee

AU - Park, Hong Seok

AU - Kim, Chul Hwan

AU - Kwon, Soon Young

AU - Kim, Je-Jong

AU - Cheon, Jun

AU - Lee, Jeong Gu

PY - 2013/8/1

Y1 - 2013/8/1

N2 - We examined the correlation between laminin 332 and malignancy in bladder cancer patients, and, using a strain of invasive bladder cancer cells, determined whether laminin 332 causes bladder cancer motility and invasion. To investigate the correlation between laminin 332 g2 distribution and patient outcome, we performed a semiquantitative immunohistochemical analysis of 35 paraffin-embedded samples using the antibody D4B5, which is specific for the laminin 5 γ2 chain. To evaluate the role of laminin 332 in NBT-II cell motility and invasion, we used a scratch assay and the Boyden chamber chemoinvasion system. Tumor stage and grade were significantly correlated with a loss of laminin 332 γ2 chain from the basement membrane (p = 0.001) and its retention in the cytoplasm (p = 0.001) (Kruskal-Wallis test). Kaplan-Meier survival curves revealed an association between the risk of progression and cytoplasmic retention of the laminin 332 γ2 chain. In addition, an in vitro scratch assay showed an increase in the migration of cells treated with laminin 332 from their cluster. The Boyden chamber assay showed that laminin 332 potentiated NBT-II cell invasion. Immunohistochemistry results showed that bladder cancer patients with a higher malignancy expressed more laminin 332. The in vitro scratch and invasion assay showed that laminin 332 stimulated the motility and invasion of bladder cancer cells. The invasion assay explains the correlation between laminin 332 expression and bladder cancer malignancy.

AB - We examined the correlation between laminin 332 and malignancy in bladder cancer patients, and, using a strain of invasive bladder cancer cells, determined whether laminin 332 causes bladder cancer motility and invasion. To investigate the correlation between laminin 332 g2 distribution and patient outcome, we performed a semiquantitative immunohistochemical analysis of 35 paraffin-embedded samples using the antibody D4B5, which is specific for the laminin 5 γ2 chain. To evaluate the role of laminin 332 in NBT-II cell motility and invasion, we used a scratch assay and the Boyden chamber chemoinvasion system. Tumor stage and grade were significantly correlated with a loss of laminin 332 γ2 chain from the basement membrane (p = 0.001) and its retention in the cytoplasm (p = 0.001) (Kruskal-Wallis test). Kaplan-Meier survival curves revealed an association between the risk of progression and cytoplasmic retention of the laminin 332 γ2 chain. In addition, an in vitro scratch assay showed an increase in the migration of cells treated with laminin 332 from their cluster. The Boyden chamber assay showed that laminin 332 potentiated NBT-II cell invasion. Immunohistochemistry results showed that bladder cancer patients with a higher malignancy expressed more laminin 332. The in vitro scratch and invasion assay showed that laminin 332 stimulated the motility and invasion of bladder cancer cells. The invasion assay explains the correlation between laminin 332 expression and bladder cancer malignancy.

KW - Invasion

KW - Laminin 332

KW - Prognosis

KW - Urothelial cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84881087455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881087455&partnerID=8YFLogxK

U2 - 10.1016/j.kjms.2012.12.003

DO - 10.1016/j.kjms.2012.12.003

M3 - Article

VL - 29

SP - 422

EP - 429

JO - Kaohsiung Journal of Medical Sciences

JF - Kaohsiung Journal of Medical Sciences

SN - 1607-551X

IS - 8

ER -